x

Diagnosis and Treatment Archives – Page 6 of 7 – #BCSM

San Antonio Breast Cancer Symposium Highlights by Dr. Robert Miller

The San Antonio Breast Cancer Symposium is the largest scientific meeting devoted to breast cancer, attracting national and international attention. It is attended by clinicians, researchers and advocates. “The Symposium aims to achieve a balance of clinical, translational, and basic research, providing a forum for interaction, communication, and education for a broad spectrum of researchers, […]

Read more ›
Clinical Trials 101

Clinical Trials 101 – Guest Post by Carmen Gonzalez The world of clinical research can present a hornet’s nest of almost incomprehensible clinical jargon to the average Jane or Joe. Added to that reading burden is finding what study is right for you.  Assuming you have waded through all the public information, there remains the […]

Read more ›
Integrative Oncology with Lorenzo Cohen

How can men and women affected by breast cancer use complimentary therapies to better manage their cancer experience? That’s what the inquiring minds of #BCSM wanted to know. We invited Lorenzo Cohen, Ph.D., director of MD Anderson Cancer Center’s Integrative Oncology Department, to talk with us about his research and experience. Some additional information about […]

Read more ›
What’s In A Name? Cancer – or Indolent Lesions of Epithelial Origin

What’s in a name? In the case of cancer, there are myths, fears and misinformation – more than perhaps any other illness.  Cancer encompasses hundreds of different diseases and each one is complex.  Even women diagnosed with exactly the same ‘type’ of breast cancer and who undergo the same treatment can have very different outcomes.  […]

Read more ›
Endocrine Therapy Side Effects – Follow Up from ASBrS

In May 2013, I was invited to give a talk with my colleague Dr. Carol Connor at the annual meeting of the American Society of Breast Surgeons.  Our topic was “Endocrine Therapy for Breast Cancer”, and we discussed the literature supporting the use of tamoxifen and aromatase inhibitors for breast cancer, as well as adverse effects and treatment of […]

Read more ›